Skip to Main Content

Advertisement

Skip Nav Destination

Issues

TOP READS

J Immunol (2023) 211 (12): 1749.

CUTTING EDGE

J Immunol (2023) 211 (12): 1751–1755.

  • CCR8 facilitates IL-25–induced skin and lung ILC2 increase and production of IL-13.

  • CCR8 regulates IL-33–responsive skin ILC2 increase and production of IL-13/IL-5.

  • CCR8 controls IL-25–induced ILC2 skin and lung homing and IL-33–induced skin homing.

J Immunol (2023) 211 (12): 1756–1761.

  • IL-6 and TGF-β signaling induces CXCR5 expression in Bach2-deficient CD4+ T cells.

  • IL-6 increases Bach2 at protein but not mRNA levels in a STAT3-dependent manner.

  • IL-6/STAT3 controls Tfh versus Th17 differentiation via an incoherent feedforward loop.

J Immunol (2023) 211 (12): 1762–1766.

  • Serpine1 inhibits EAE in a T cell–dependent manner.

  • Serpine1 is upregulated in Th1 cells and inhibits their pathogenicity.

  • Serpine1 promotes expression and function of the Th1-specific inhibitory receptor Tim-3.

ANTIGEN RECOGNITION AND RESPONSES

J Immunol (2023) 211 (12): 1767–1782.

  • LKB1-mediated SIK activation regulates HDAC7 stability.

  • HDAC7 stabilization correlates with epigenetic restriction of cytokine loci.

  • Inhibition of this pathway epigenetically poises cells for enhanced cytokine recall.

CLINICAL AND HUMAN IMMUNOLOGY

J Immunol (2023) 211 (12): 1806–1813.

  • GLP-1R agonists attenuate ex vivo human platelet activation and proinflammatory mediators.

  • GLP-1R agonists target platelets/platelet-dependent airway inflammation in an AERD model.

  • The GLP-1R axis may regulate platelet-mediated inflammation in asthma.

IMMUNE REGULATION

J Immunol (2023) 211 (12): 1814–1822.

  • The TRAF2/3 and TRAF6 binding motifs of CD40 are critically involved in EAE induction.

  • Both motifs are involved in priming pathogenic T cells by DCs.

  • The TRAF2/3 motif, but not the TRAF6 motif, is required for TD antibody responses.

INFECTIOUS DISEASE AND HOST RESPONSE

J Immunol (2023) 211 (12): 1823–1834.

  • HOIL1 restricts early intestinal replication and systemic spread of C. rodentium.

  • HOIL1 functions partly in myeloid cells to limit morbidity and systemic spread.

  • HOIL1 promotes ILC3 expansion and IL-22 expression during C. rodentium infection.

INNATE IMMUNITY AND INFLAMMATION

J Immunol (2023) 211 (12): 1835–1843.

  • Oxidative stress induces E-selectin expression by downregulation of ERG.

  • ERG represses the E-selectin promoter activity through the −127 ERG binding motif.

  • ERG decreases oxidative stress–induced monocyte-endothelial adhesion.

TUMOR IMMUNOLOGY

J Immunol (2023) 211 (12): 1844–1857.

  • NLRX1 functions as a mammary tumor suppressor when expressed in host cells.

  • NLRX1 exacerbates mammary tumor progression when expressed in 4T1 cells.

  • NLRX1 augments 4T1 aggressiveness through regulation of multiple cancer hallmarks.

J Immunol (2023) 211 (12): 1858–1867.

  • Not all mice respond to immune checkpoint therapy.

  • We correlate tumor-infiltrating lymphocytes with checkpoint therapy success.

  • Regressing mice have increased T cells and decreased macrophages/monocytes.

NOVEL IMMUNOLOGICAL METHODS

J Immunol (2023) 211 (12): 1868–1876.

  • Cold mechanical isolation versus enzymatic digestion reduces macrophage activation.

  • Limiting isolation procedure–induced cell activation improves analysis reliability.

Close Modal

or Create an Account

Close Modal
Close Modal